P15056 (BRAF_HUMAN) Homo sapiens (Human)

Serine/threonine-protein kinase B-raf UniProtKBInterProInteractive Modelling

766 aa; Sequence (Fasta) ; 2 identical sequences: Pan troglodytes: A0A2I3TK00; Pan paniscus: A0A2R9BBV0

Available Structures

114 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Cryo-EM structure of a RAS/RAF complex (state 2)
8dgt
 Heteromer
P01116; Q02750; V9P4T4; 		151-738
2×AGS; 2×ZN; 2×MG; 1×LCJ; 1×GNP;
Assess
Cryo-EM structure of a RAS/RAF complex (state 1)
8dgs
 Heteromer
P01116; Q02750; V9P4T4; 		155-738
2×AGS; 2×ZN; 2×MG; 1×LCJ; 1×GNP;
Assess
Autoinhibited BRAF:(14-3-3)2:MEK complex with the BRAF RBD resolved
7mfd
 Heteromer
P63104; Q02750; 		156-738
2×ZN; 1×CHU;
Assess
Autoinhibited BRAF:(14-3-3)2 complex with the BRAF RBD resolved
7mfe
 Heteromer
P63104; 		156-738
2×ZN;
Assess
Structure of a MAPK pathway complex
6nyb
 Heteromer
Q02750; V9P4T4; 		233-738
1×AGS; 2×ZN; 1×ADP; 1×MG; 1×LCJ;
Assess
B-Raf:14-3-3 complex
6uan
 Heteromer
A0A068JLL8; 		449-750
Assess
Structure of a MAPK pathway complex
6q0k
 Heteromer
P63104; 		449-737
Assess
BRAF dimer bound to 14-3-3
6u2h
 Heteromer
P63104; 		448-733
2×29L;
Assess
Apo BRAF dimer bound to 14-3-3
6xag
 Heteromer
P63104; 		448-733
1×EDO;
Assess
Structure of a MAPK pathway complex
6q0j
 Heteromer
Q02750; V9P4T4; 		449-734
2×MG; 2×LCJ; 2×AGS;
Assess
Dimeric (BRAF)2:(14-3-3)2 complex bound to SB590885 Inhibitor
7mff
 Heteromer
P63104; 		449-733
2×215;
Assess
Structure of a MAPK pathway complex
6q0t
 Heteromer
Q02750; V9P4T4; 		449-732
1×MG; 1×LCJ; 1×AGS;
Assess
Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP and PD0325901
7m0x
 Heteromer
Q02750; 		447-722
2×ANP; 2×MG; 1×CL; 1×4BM; 2×SO4; 2×GOL;
Assess
Crystal structure of BRAF:MEK1 complex
6pp9
 Heteromer
Q02750; 		447-722
2×ANP; 2×MG; 2×CL; 1×LCJ; 1×SO4; 2×GOL;
Assess
Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP
6v2w
 Heteromer
Q02750; 		447-721
2×ANP; 2×MG;
Assess
Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP and Trametinib
7m0y
 Heteromer
Q02750; 		447-721
2×ANP; 2×MG; 1×SO4; 1×QOM;
Assess
Crystal structure of BRAF/MEK complex with NST-628 and inactive RAF
9axy
 Heteromer
Q02750; 		448-722
2×ANP; 2×MG; 1×A1AHE;
Assess
Crystal structure of the BRAF:MEK1 complex
4mne
 Heteromer
Q02750; 		449-722
2×ACP; 2×MG; 2×573;
Assess
Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP and Pimasertib
7m0w
 Heteromer
Q02750; 		448-721
2×ANP; 2×MG; 1×QOA;
Assess
Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP and Binimetinib
7m0u
 Heteromer
Q02750; 		449-722
2×ANP; 2×MG; 1×QO7;
Assess
Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP and Cobimetinib
7m0v
 Heteromer
Q02750; 		449-722
2×ANP; 2×MG; 1×EUI;
Assess
Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP and Selumetinib
7m0t
 Heteromer
Q02750; 		448-721
1×3EW; 2×ANP; 2×MG;
Assess
Crystal structure of BRAF/MEK1 complex with NST-628 and an active RAF dimer
9axx
 Heteromer
Q02750; 		449-721
3×ANP; 1×TRS; 11×EDO; 2×A1AHE; 2×MG;
Assess
Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP and CH5126766
7m0z
 Heteromer
Q02750; 		449-721
2×ANP; 2×MG; 1×SO4; 1×CHU;
Assess
BRAF-MEK complex with AMP-PCP bound to BRAF
6u2g
 Heteromer
Q02750; 		451-722
2×ACP; 2×MG; 1×SO4;
Assess
CryoEM structure of HSP90-CDC37-BRAF(V600E) complex.
7zr0
 Heteromer
P08238; Q16543; 		521-724
2×ATP;
Assess
CryoEM structure of HSP90-CDC37-BRAF(V600E)-PP5(open) complex
7zr6
 Heteromer
P08238; P53041; Q16543; 		521-724
2×ATP;
Assess
CryoEM structure of HSP90-CDC37-BRAF(V600E)-PP5(closed) complex
7zr5
 Heteromer
P08238; P53041; Q16543; 		521-724
2×ATP;
Assess
Crystal structure of bRaf in complex with inhibitor GNE-0749
7k0v
homo-4-mer448-722
4×VQP; 2×CL;
Assess
BRAF in complex with an organic inhibitor 7898734
4e26
homo-2-mer448-723
2×734;
Assess
The complex of wild type B-RAF and BAY439006.
1uwh
homo-2-mer448-723
2×BAX; 1×CL;
Assess
Crystal structure of BRAF kinase domain bound to the inhibitor 2l
6nsq
homo-2-mer447-722
2×KZP;
Assess
B-Raf Kinase Domain in Complex with an Aminothienopyrimidine-based Inhibitor
4ehe
homo-2-mer448-723
2×RI8;
Assess
The complex of mutant V599E B-RAF and BAY439006.
1uwj
homo-2-mer448-723
2×BAX;
Assess
B-Raf Kinase Domain in Complex with an Aminopyridimine-based Inhibitor
4ehg
homo-2-mer448-723
2×RI9;
Assess
Human B-Raf Kinase Domain in Complex with an Imidazopyridine-based Inhibitor
4mbj
homo-2-mer448-723
2×DFS;
Assess
Crystal Structure of Human B-raf bound to a DFG-out Inhibitor TAK-632
4ksp
homo-2-mer448-722
2×1SU;
Assess
Crystal Structure of Human Kinase Domain of B-raf with a DFG-out Inhibitor
4fc0
homo-2-mer448-722
2×0T2;
Assess
Crystal structure of BRAF kinase domain bound to the PROTAC P4B
6uuo
homo-2-mer448-722
2×QH1;
Assess
Crystal Structure of Human B-raf bound to a DFG-out Inhibitor 5B
4ksq
homo-2-mer448-722
2×1SW;
Assess
BRAF kinase in complex with TAK580 (tovorafenib)
8f7o
homo-2-mer449-723
2×QOP;
Assess
Crystal structure of BRAF V600E in complex with a hybrid compound 6
8c7y
homo-2-mer448-721
19×EDO; 1×NO3; 2×TXV;
Assess
Crystal structure of BRAF in complex with a hybrid compound 6
8c7x
homo-2-mer448-721
17×EDO; 3×BR; 2×TXV;
Assess
The co-crystal structure of BRAF(V600E) with ponatinib
6p3d
homo-2-mer448-721
2×0LI; 16×SO4; 2×NH4; 4×EDO;
Assess
BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-3-VEM
5jsm
homo-2-mer448-721
4×DMS; 2×BEN; 3×EOH; 1×6NB; 2×CL; 1×GOL;
Assess
BRAF Kinase domain b3aC loop deletion mutant in complex with AZ628
5hid
homo-2-mer449-722
2×B1E; 2×PEG;
Assess
B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX3203
4fk3
homo-2-mer448-721
1×325;
Assess
BRAF kinase in complex with LXH254 (naporafenib)
8f7p
homo-2-mer448-721
2×K81;
Assess
B-Raf kinase domain in complex with a tetrahydronaphthalene inhibitor
3q96
homo-2-mer449-722
2×0NF;
Assess
Crystal Structure of the Kinase domain of Human B-raf with a [1,3]thiazolo[5,4-b]pyridine derivative
4dbn
homo-2-mer448-721
2×0JA;
Assess
Crystal structure of BRAF (R509H) kinase domain bound to AZ628
4rzw
homo-2-mer448-721
2×B1E;
Assess
BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-6-VEM
5jrq
homo-2-mer448-720
2×6N9; 2×DMS; 1×GOL; 2×TMA;
Assess
The co-crystal structure of BRAF(V600E) with PHI1
6p7g
homo-2-mer449-721
2×E7M; 1×NHE;
Assess
Crystal structure of BRAF kinase domain bound to GDC0879
7shv
homo-2-mer449-721
2×29L; 2×CL;
Assess
B-Raf wild-type kinase domain in complex with a purinylpyridinylamino-based inhibitor
5fd2
homo-2-mer448-720
2×5XJ;
Assess
Crystal Structure of BRAF kinase domain bound to Belvarafenib
6xfp
homo-2-mer449-720
2×V1Y; 12×CL;
Assess
B-Raf V600E structure bound to a new inhibitor
7p3v
homo-2-mer448-719
2×5I4;
Assess
Crystal structure of bRaf in complex with inhibitor
6xlo
homo-2-mer449-720
2×V5J; 1×IOD;
Assess
BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-BISAMIDE
5jt2
homo-2-mer448-719
2×BEN; 1×6NC;
Assess
Crystal structure of BRAF-V600E bound to GDC0879
4mnf
homo-2-mer449-720
2×29L; 1×CL;
Assess
B-Raf Kinase domain in complex with PLX5568
4xv9
homo-2-mer448-705
2×1OO; 2×SO4;
Assess
B-Raf Kinase V600E oncogenic mutant in complex with Dabrafenib
4xv2
homo-2-mer448-705
2×P06;
Assess
B-Raf Kinase V600E oncogenic mutant in complex with PLX7922
4xv3
homo-2-mer448-705
1×P02;
Assess
B-Raf Kinase V600E oncogenic mutant in complex with PLX7904
4xv1
homo-2-mer449-705
1×904;
Assess
Crystal structure of the RBD domain of serine/threonine-protein kinase B-raf from Homo sapiens. Nor…
3ny5
homo-2-mer153-235
Assess
Crystal structure of the BRS domain of BRAF in complex with the CC-SAM domain of KSR1
5vyk
homo-2-mer36-105
2×GOL;
Assess
BRAF in complex with N-(4-methyl-3-(1-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)phenyl)-3-(…
6n0q
monomer446-721
1×K7S;
Assess
Pyrazole-based inhibitors of B-Raf kinase
3d4q
monomer448-723
1×SM5;
Assess
Crystal Structure of Human B-Raf Kinase Domain in Complex with a Non-Oxime Furopyridine Inhibitor
3prf
monomer448-723
1×FP3;
Assess
Human B-Raf Kinase in Complex with a Non-Oxime Furopyridine Inhibitor
3ppk
monomer448-723
1×FNI;
Assess
Crystal Structure of Wild Type BRAF kinase domain in complex with organometallic inhibitor CNS292
3q4c
monomer448-723
1×RSW;
Assess
Human B-Raf Kinase in Complex with an Amide Linked Pyrazolopyridine Inhibitor
3skc
monomer448-723
1×BR2;
Assess
Human B-Raf Kinase Domain in Complex with a Methoxypyrazolopyridinyl Benzamide Inhibitor
3tv6
monomer448-723
1×B0R;
Assess
Human B-Raf Kinase Domain in Complex with an Bromopyridine Benzamide Inhibitor
3tv4
monomer448-723
1×TV4;
Assess
Furo[2,3-c]pyridine-based Indanone Oximes as Potent and Selective B-Raf Inhibitors
3psb
monomer448-723
1×SM6;
Assess
Crystal Structure of Human B-Raf Kinase in Complex with a Non-Oxime Furopyridine Inhibitor
3pri
monomer448-723
1×FP4;
Assess
Human B-Raf Kinase Domain bound to a Type II Pyrazolopyridine Inhibitor
4g9c
monomer448-723
1×0WP;
Assess
Non-oxime pyrazole based inhibitors of B-Raf kinase
3psd
monomer448-723
1×SM7;
Assess
Human B-Raf Kinase in Complex with a Furopyridine Inhibitor
3ppj
monomer448-723
1×FOI;
Assess
BRAF in Complex with N-(3-(tert-butyl)phenyl)-4-methyl-3-(6-morpholinopyrimidin-4-yl)benzamide
5val
monomer446-720
1×92D;
Assess
B-Raf Kinase in Complex with Birb796
4jvg
monomer448-722
1×B96;
Assess
BRAF in complex with compound 3
4h58
monomer448-722
1×10Z;
Assess
Crystal structure of RAF kinase domain bound to the inhibitor 2a
6cad
monomer449-722
1×EU4;
Assess
B-Raf Kinase in Complex with PLX4720
3c4c
monomer448-721
1×324;
Assess
Crystal structure of a BRAF kinase domain monomer
4wo5
monomer448-721
1×324;
Assess
Structure of BRAF in Complex With Exarafenib (KIN-2787).
8qqg
monomer449-722
1×WJ9; 3×CL;
Assess
BRAF Kinase domain b3aC loop deletion mutant in complex with dabrafenib
5hie
monomer449-722
1×P06;
Assess
B-Raf V600E Kinase Domain Bound to a Type II Dihydroquinazoline Inhibitor
4g9r
monomer448-721
1×B1E;
Assess
Highly Potent and Selective 3-N-methylquinazoline-4(3H)-one Based Inhibitors of B-RafV600E Kinase
4pp7
monomer448-721
1×2VX;
Assess
Crystal Structure of B-Raf Kinase Domain in Complex with a Dihydropyrido[2,3-d]pyrimidinone-based I…
4e4x
monomer448-721
1×T1Q;
Assess
BRAF in Complex with RAF709
5vam
monomer449-721
1×92J;
Assess
BRAF in complex with N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluo…
6n0p
monomer449-721
1×K81;
Assess
CRYSTAL STRUCTURE OF B-RAF IN COMPLEX WITH BI 882370
5csx
monomer448-720
1×54J; 1×GLC;
Assess
BRAF Kinase domain b3aC loop deletion mutant in complex with sorafenib
5hi2
monomer449-721
1×BAX;
Assess
B-RAF in complex with Dabrafenib
5csw
monomer449-721
1×P06;
Assess
The Complex of wild-type B-RAF with Pyrazolo pyrimidine inhibitor
3ii5
monomer448-720
1×831; 2×PO4;
Assess
Crystal structure of the BRAF (R509H) kinase domain monomer bound to Vemurafenib
4rzv
monomer449-721
1×032;
Assess
Crystal structure of BRAF V600E oncogenic mutant in complex with TAK-580
6v34
monomer449-721
1×QOP;
Assess
BRAF in Complex with RAF265
5ct7
monomer449-721
1×55J;
Assess
Crystal structure of the insect cell-expressed WT-BRAF kinase in complex with Dabrafenib
6v2u
monomer449-721
1×P06; 1×CL;
Assess
B-Raf Kinase V600E mutant in complex with a diarylthiazole B-Raf Inhibitor
4cqe
monomer449-720
1×CQE;
Assess
B-Raf Kinase V600E oncogenic mutant in complex with PLX4032
3og7
monomer449-720
1×032;
Assess
Crystals Structure of B-Raf kinase domain in complex with an Imidazopyridinyl benzamide inhibitor
6b8u
monomer449-720
1×8EN;
Assess
B-Raf V600E kinase domain in complex with an aminoisoquinoline inhibitor
3idp
monomer449-720
1×L1E;
Assess
CRYSTAL STRUCTURE OF BRAF(V600E) IN COMPLEX WITH LY3009120 COMPND
5c9c
monomer449-720
1×4Z5;
Assess
Structure of the B-Raf kinase domain bound to SB-590885
2fb8
monomer449-720
1×215;
Assess
The complex structure of Braf V600E kinase domain with a novel Braf inhibitor
4r5y
monomer449-720
1×3K3;
Assess
Crystal Structure of BRAF Kinase Domain Bound to AZ-VEM
5ita
monomer448-718
1×6DC;
Assess
bRaf complexed with an inhibitor
4yht
monomer449-719
1×GOL; 1×4EF;
Assess
Solution NMR Structure of the Ras-binding domain of Serine/threonine-protein kinase B-raf from Homo…
2l05
monomer149-232
Assess
Solution structure of Ras Binding Domain (RBD) of B-Raf
5j2r
monomer151-232
1×6FS;
Assess
Solution structure of Ras Binding Domain (RBD) of B-Raf complexed with Rigosertib (Complex I)
5j18
monomer151-232
1×6FS;
Assess
Solution structure of Ras Binding Domain (RBD) of B-Raf
5j17
monomer151-230
Assess
Crystal structure of the BRS domain of BRAF
5vr3
monomer41-102
1×SO4;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8dgs.1.Amonomer0.65155-738
1×AGS; 2×ZN;100.00
Assess
7z37.1.Cmonomer0.55514-723
62.35
Assess